Full Text View
Tabular View
No Study Results Posted
Related Studies
A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
This study is ongoing, but not recruiting participants.
Study NCT00724334   Information provided by Sanofi

First Received on July 17, 2008.   Last Updated on February 12, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myelofibrosis
Additional conditions recognized in this trial
Primary Myelofibrosis
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Myeloproliferative Disorders
Interventions listed in this trial
SAR302503 (TG101348)
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services